Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.480
-0.060 (-3.90%)
At close: Mar 28, 2025, 4:00 PM
1.507
+0.027 (1.83%)
After-hours: Mar 28, 2025, 4:18 PM EDT
Metagenomi Revenue
In the year 2024, Metagenomi had annual revenue of $52.30M with 16.84% growth. Metagenomi had revenue of $9.61M in the quarter ending December 31, 2024, a decrease of -22.46%.
Revenue (ttm)
$52.30M
Revenue Growth
+16.84%
P/S Ratio
0.97
Revenue / Employee
$258,886
Employees
202
Market Cap
55.33M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 52.30M | 7.54M | 16.84% |
Dec 31, 2023 | 44.76M | 27.56M | 160.21% |
Dec 31, 2022 | 17.20M | 16.96M | 6,978.19% |
Dec 31, 2021 | 243.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMGX News
- 11 days ago - Metagenomi Reports Business Updates and Full Year 2024 Financial Results - GlobeNewsWire
- 15 days ago - Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems - GlobeNewsWire
- 6 weeks ago - Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference - GlobeNewsWire
- 2 months ago - Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones - GlobeNewsWire
- 2 months ago - Metagenomi Announces New Appointment to its Board of Directors - GlobeNewsWire
- 2 months ago - Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV” - GlobeNewsWire
- 3 months ago - Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting - GlobeNewsWire